Viemed Healthcare Files 8-K Report
Ticker: VMD · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1729149
| Field | Detail |
|---|---|
| Company | Viemed Healthcare, Inc. (VMD) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Viemed Healthcare filed a standard 8-K, no major news yet.
AI Summary
On April 2, 2024, Viemed Healthcare, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard reporting event for the company.
Why It Matters
This filing serves as a public record of Viemed Healthcare's regulatory disclosures and financial reporting, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that suggests an immediate change in risk for the company.
Key Players & Entities
- VIEMED HEALTHCARE, INC. (company) — Registrant
- April 2, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Viemed Healthcare, Inc.
On what date was this report filed?
The report was filed on April 2, 2024.
What is Viemed Healthcare's principal executive office address?
Viemed Healthcare's principal executive office is located at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508.
What is the company's telephone number?
The company's telephone number is (337) 504-3802.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-04-02 09:07:58
Filing Documents
- vmd-20240402.htm (8-K) — 30KB
- ex99104022024.htm (EX-99.1) — 12KB
- vmdlogo002.jpg (GRAPHIC) — 97KB
- 0001729149-24-000088.txt ( ) — 301KB
- vmd-20240402.xsd (EX-101.SCH) — 2KB
- vmd-20240402_lab.xml (EX-101.LAB) — 21KB
- vmd-20240402_pre.xml (EX-101.PRE) — 12KB
- vmd-20240402_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure On April 2, 2024 , Viemed Healthcare, Inc. (the "Company") issued a press release announcing the finalization of its strategic partnership with East Alabama Health, providing the Company with the controlling interest of East Alabama HomeMed, LLC. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information and Exhibit 99.1 be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release dated April 2, 2024 104 Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 2, 2024 VIEMED HEALTHCARE, INC. By: /s/ Trae Fitzgerald Trae Fitzgerald Chief Financial Officer